Allscripts Healthcare Solutions, Inc. (MDRX) Stock Rating Reaffirmed by SunTrust Banks, Inc.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)‘s stock had its “buy” rating reissued by stock analysts at SunTrust Banks, Inc. in a report released on Friday, November 3rd. They presently have a $16.00 price objective on the software maker’s stock. SunTrust Banks, Inc.’s price target would suggest a potential upside of 27.29% from the stock’s previous close.

Other equities analysts have also recently issued reports about the company. Dougherty & Co restated a “buy” rating and set a $16.00 price objective (up from $15.00) on shares of Allscripts Healthcare Solutions in a research note on Tuesday, October 3rd. Cantor Fitzgerald restated a “buy” rating and set a $17.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Wednesday, September 27th. Jefferies Group LLC set a $17.00 target price on Allscripts Healthcare Solutions and gave the stock a “buy” rating in a research report on Friday, August 25th. Maxim Group reaffirmed a “buy” rating and issued a $16.00 target price on shares of Allscripts Healthcare Solutions in a research report on Friday, August 4th. Finally, Robert W. Baird reaffirmed a “buy” rating and issued a $16.00 target price on shares of Allscripts Healthcare Solutions in a research report on Tuesday, October 17th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and eleven have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $15.06.

Allscripts Healthcare Solutions (NASDAQ MDRX) opened at $12.57 on Friday. The company has a market capitalization of $2,271.16, a P/E ratio of 29.23, a PEG ratio of 2.24 and a beta of 1.35. The company has a debt-to-equity ratio of 1.20, a quick ratio of 0.98 and a current ratio of 0.98. Allscripts Healthcare Solutions has a one year low of $9.96 and a one year high of $14.45.

WARNING: “Allscripts Healthcare Solutions, Inc. (MDRX) Stock Rating Reaffirmed by SunTrust Banks, Inc.” was originally posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this piece on another domain, it was stolen and reposted in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://ledgergazette.com/2017/11/13/allscripts-healthcare-solutions-mdrx-buy-rating-reaffirmed-at-suntrust-banks-inc.html.

In related news, CEO Paul Black sold 15,000 shares of the business’s stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $13.52, for a total value of $202,800.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Brian Farley sold 5,000 shares of the business’s stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $13.52, for a total value of $67,600.00. Following the completion of the sale, the executive vice president now directly owns 196,607 shares in the company, valued at approximately $2,658,126.64. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 35,000 shares of company stock worth $473,800. Company insiders own 0.91% of the company’s stock.

A number of institutional investors have recently bought and sold shares of the business. World Asset Management Inc boosted its stake in Allscripts Healthcare Solutions by 0.7% in the second quarter. World Asset Management Inc now owns 11,419 shares of the software maker’s stock worth $146,000 after purchasing an additional 81 shares in the last quarter. Atlantic Trust Group LLC raised its position in shares of Allscripts Healthcare Solutions by 0.3% during the second quarter. Atlantic Trust Group LLC now owns 32,900 shares of the software maker’s stock worth $420,000 after acquiring an additional 110 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its position in shares of Allscripts Healthcare Solutions by 0.4% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 26,484 shares of the software maker’s stock worth $338,000 after acquiring an additional 115 shares during the last quarter. Bank of Montreal Can raised its position in shares of Allscripts Healthcare Solutions by 6.9% during the second quarter. Bank of Montreal Can now owns 10,603 shares of the software maker’s stock worth $135,000 after acquiring an additional 689 shares during the last quarter. Finally, Amalgamated Bank raised its position in shares of Allscripts Healthcare Solutions by 3.0% during the first quarter. Amalgamated Bank now owns 29,551 shares of the software maker’s stock worth $375,000 after acquiring an additional 868 shares during the last quarter.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply